Daniel Tillett Takes 5.26% Stake in Island Pharmaceuticals

Island Pharmaceuticals Ltd (AU:ILA) has released an update.

Daniel Tillett has emerged as a substantial holder in Island Pharmaceuticals Limited, acquiring a 5.26% stake with 8,113,434 ordinary shares. His interest in the company was established on October 11, 2024, with the recent acquisition amounting to $553,940.38 for 7,913,434 shares, alongside an earlier purchase of 200,000 shares for $40,400.

For further insights into AU:ILA stock, check out TipRanks’ Stock Analysis page.